Learn how to facilitate growth while ensuring that your plans are supported by sound financial data and effective company execution.
Named by FORTUNE magazine as 2013's fastest-growing company, Jazz Pharmaceuticals is a specialty biopharmaceutical company with a product portfolio that includes the highly successful XYREM®, a medication used to treat symptoms associated with narcolepsy.
Find out how Jazz Pharmaceuticals' implementation of a cloud-based EPM suite has enabled it to achieve rapid growth and multiple acquisitions without putting undue strain on its financial team or compromising its data analysis capabilities.
Offered Free by: Host Analytics, Inc
See All Resources from: Host Analytics, Inc
This download should complete shortly. If the resource doesn't automatically download, please, click here.